Sector Update: Health Care Stocks Softer Late Afternoon

MT Newswires Live2024-12-31

Health care stocks were declining late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling 1.1%.

The iShares Biotechnology ETF (IBB) dropped 1.3%.

In corporate news, Inogen (INGN) shares rose nearly 6% after the company said Monday it received US Food and Drug Administration clearance for its Simeox 200 airway clearance device, which is designed to help people with chronic respiratory diseases manage bronchial drainage.

Rocket Pharmaceuticals' (RCKT) pipeline development together with its in-house manufacturing capacity are expected to support "strong" long-term growth potential for the company, Wedbush said in a note. Wedbush initiated Rocket with an outperform rating and a $32 price target. Rocket shares added 2.4%.

Marinus Pharmaceuticals (MRNS) shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.

Emergent BioSolutions (EBS) shares jumped 12% after HC Wainwright started coverage of the stock with a buy rating and a $15 price target.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2495474508?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-31 04:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495474508","market":"sh","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Softer Late Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were declining late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling 1.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) dropped 1.3%.</p><p>In corporate news, Inogen (INGN) shares rose nearly 6% after the company said Monday it received US Food and Drug Administration clearance for its Simeox 200 airway clearance device, which is designed to help people with chronic respiratory diseases manage bronchial drainage.</p><p>Rocket Pharmaceuticals' (RCKT) pipeline development together with its in-house manufacturing capacity are expected to support \"strong\" long-term growth potential for the company, Wedbush said in a note. Wedbush initiated Rocket with an outperform rating and a $32 price target. Rocket shares added 2.4%.</p><p><a href=\"https://laohu8.com/S/MRNS\">Marinus Pharmaceuticals</a> (MRNS) shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.</p><p>Emergent BioSolutions (EBS) shares jumped 12% after HC Wainwright started coverage of the stock with a buy rating and a $15 price target.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Softer Late Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Softer Late Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-31 04:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were declining late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling 1.1%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) dropped 1.3%.</p><p>In corporate news, Inogen (INGN) shares rose nearly 6% after the company said Monday it received US Food and Drug Administration clearance for its Simeox 200 airway clearance device, which is designed to help people with chronic respiratory diseases manage bronchial drainage.</p><p>Rocket Pharmaceuticals' (RCKT) pipeline development together with its in-house manufacturing capacity are expected to support \"strong\" long-term growth potential for the company, Wedbush said in a note. Wedbush initiated Rocket with an outperform rating and a $32 price target. Rocket shares added 2.4%.</p><p><a href=\"https://laohu8.com/S/MRNS\">Marinus Pharmaceuticals</a> (MRNS) shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.</p><p>Emergent BioSolutions (EBS) shares jumped 12% after HC Wainwright started coverage of the stock with a buy rating and a $15 price target.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2495474508","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495474508","pubTimestamp":1735592176,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were declining late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each falling 1.1%.The iShares Biotechnology ETF  dropped 1.3%.In corporate news, Inogen  shares rose nearly 6% after the company said Monday it received US Food and Drug Administration clearance for its Simeox 200 airway clearance device, which is designed to help people with chronic respiratory diseases manage bronchial drainage.Rocket Pharmaceuticals'  pipeline development together with its in-house manufacturing capacity are expected to support \"strong\" long-term growth potential for the company, Wedbush said in a note. Wedbush initiated Rocket with an outperform rating and a $32 price target. Rocket shares added 2.4%.Marinus Pharmaceuticals  shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.Emergent BioSolutions  shares jumped 12% after HC Wainwrigh","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","INGN":"Inogen Inc","EBS":"Emergent Biosolutions","BK4082":"医疗保健设备","BK4139":"生物科技","XLV":"健康照护类股ETF-SPDR","BK4581":"高盛持仓","BK4588":"碎股","IBB":"生物科技指数ETF-iShares Nasdaq","RCKT":"Rocket Pharmaceuticals, Inc.","BK4007":"制药","MRNS":"Marinus Pharmaceuticals","BK4583":"猴痘概念"},"translate_title":"行业更新：医疗保健股午后走软","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNS":0.9,"RCKT":0.9,"EBS":0.9,"IBB":1,"INGN":0.9,"XLV":1},"content_text":"Health care stocks were declining late Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each falling 1.1%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Inogen (INGN) shares rose nearly 6% after the company said Monday it received US Food and Drug Administration clearance for its Simeox 200 airway clearance device, which is designed to help people with chronic respiratory diseases manage bronchial drainage.Rocket Pharmaceuticals' (RCKT) pipeline development together with its in-house manufacturing capacity are expected to support \"strong\" long-term growth potential for the company, Wedbush said in a note. Wedbush initiated Rocket with an outperform rating and a $32 price target. Rocket shares added 2.4%.Marinus Pharmaceuticals (MRNS) shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.Emergent BioSolutions (EBS) shares jumped 12% after HC Wainwright started coverage of the stock with a buy rating and a $15 price target.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2495474508","isCrawlerRequest":true}